Actively Recruiting
Whey Protein Ingestion and Glucose Control in Pre- and Post Diabetic Individuals
Led by University of Arkansas · Updated on 2026-04-06
40
Participants Needed
1
Research Sites
110 weeks
Total Duration
On this page
Sponsors
U
University of Arkansas
Lead Sponsor
N
National Dairy Council
Collaborating Sponsor
AI-Summary
What this Trial Is About
To examine the effects of twice daily whey protein consumption on blood glucose and insulin in pre-diabetic and diabetic individuals
CONDITIONS
Official Title
Whey Protein Ingestion and Glucose Control in Pre- and Post Diabetic Individuals
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Males and females ages 50-70 years
- Body mass index between 25-45 kg/m2
- Capable of providing informed consent
- COVID-19 negative and/or asymptomatic
- Willing to abstain from drinking alcohol or consuming marijuana and CBD products during the 7-day study meal periods on two occasions
- HbA1c: 5.7-6.4% or 6.5% to 7.5% or fasting glucose 32 100 mg/dL
You will not qualify if you...
- Does not or will not eat dairy protein sources
- Taking exogenous insulin injections or GLP/GIP injections or other appetite suppressants
- Unwilling to keep a detailed 7-day food journal on two occasions
- Unwilling to wear a continuous glucose monitor for 7 days on two occasions and share data
- Lactose intolerance
- Hemoglobin < 10 g/dL at screening
- History of chemotherapy or radiation therapy for cancer in the 6 months prior to enrollment
- History of gastrointestinal bypass or reduction surgery
- Pregnant or lactating individuals
- History of a chronic inflammatory disease such as Lupus or Crohn's disease
- Currently receiving androgen or anabolic therapy (e.g., testosterone, growth hormone, IGF-I)
- Currently using corticosteroid medications (e.g., cortisone, hydrocortisone, prednisone)
- Unwilling to avoid using protein or amino acid supplements during participation
- Unwilling to fast overnight
- Any medical condition or medication that the principal investigator or clinical study staff finds contradictory to this study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States, 72202
Actively Recruiting
Research Team
A
Arny Ferrando, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here